Cargando…
Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs
After decades of research and development, synthetic nucleic acids are beginning to enjoy significant success in the clinic. Approved drugs have increased interest in the field, and many basic research studies have focused on synthetic nucleic acids to control the action of messenger RNA and noncodi...
Autores principales: | Gagnon, Keith T., Corey, David R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555184/ https://www.ncbi.nlm.nih.gov/pubmed/30907681 http://dx.doi.org/10.1089/nat.2018.0772 |
Ejemplares similares
-
Molecular Mechanisms of Antisense Oligonucleotides
por: Crooke, Stanley T.
Publicado: (2017) -
Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
por: Synofzik, Matthis, et al.
Publicado: (2022) -
Technical Considerations for Use of Oligonucleotide Solution API
por: Muslehiddinoglu, Jale, et al.
Publicado: (2020) -
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
por: DeCollibus, Daniel Paul, et al.
Publicado: (2023) -
Perspectives on the Designation of Oligonucleotide Starting Materials
por: Kiesman, William F., et al.
Publicado: (2021)